Kovai Medical Center Q1 FY27: Profit up 21%, Sales 15%

Key takeaway for investors

Kovai Medical Center and Hospital Limited reported stronger year-on-year earnings for the quarter ended June 30, 2026 (Q1 FY27). Net profit rose 20.72% to ₹69.09 crore, while sales increased 15.34% to ₹430.91 crore compared with the same quarter last year. The company also reported higher total revenue and an improvement in operating performance indicators disclosed alongside the results. These numbers matter because they show the company sustained growth in both top line and bottom line in the first quarter of the financial year.

What the company reported for Q1 FY27

For the first quarter ended June 30, 2026, the company reported sales of ₹430.91 crore compared with ₹373.59 crore a year ago. It separately disclosed revenue of ₹438.65 crore versus ₹379.60 crore a year ago. Net income for the quarter came in at ₹69.09 crore compared with ₹57.23 crore in the corresponding period last year. Basic earnings per share (EPS) from continuing operations was ₹63.14 compared with ₹52.30, and diluted EPS was also ₹63.14 versus ₹52.30.

The data also included Profit Before Depreciation and Tax (PBDT) of ₹123.27 crore for the quarter, compared with ₹102.32 crore in the year-ago period. Operating margin (OPM) was reported at 28.76% versus 28.32% a year ago. Taken together, the quarter’s disclosures point to both scale-up in operations and stable-to-improving profitability metrics.

Sales versus revenue: how the figures line up

The disclosures carried both “sales” and “revenue” lines for the quarter. Sales for Q1 FY27 were stated at ₹430.91 crore, while revenue was stated at ₹438.65 crore. Total income was also presented as ₹438.65 crore (from ₹379.60 crore a year ago), consistent with the revenue figure shared in the results summary.

This distinction is common in financial reporting where “revenue” or “total income” can include items beyond core sales, depending on the reporting format. The quarter’s publication provided both sets of numbers without detailing each line item in the provided extract. Investors typically track the consistency between these measures, particularly when comparing operating performance across periods.

Profit growth and margin movement

Net profit rose to ₹69.09 crore in Q1 FY27, up from ₹57.23 crore in Q1 FY26, which is a 20.72% year-on-year increase. The company also reported a rise in PBDT to ₹123.27 crore from ₹102.32 crore. Operating margin (OPM) edged up to 28.76% from 28.32%.

The combination of higher sales and stable operating margin generally indicates the company was able to expand its operating base without diluting profitability, based on the numbers provided. However, the extract does not provide a detailed cost breakdown, so the precise drivers of margin movement are not specified here.

EPS performance in the quarter

For Q1 FY27, basic EPS was reported at ₹63.14 versus ₹52.30 in Q1 FY26, and diluted EPS matched at ₹63.14 versus ₹52.30. The EPS expansion aligns with the reported growth in net income. The release explicitly noted the EPS figures relate to continuing operations.

For equity investors, EPS is a key per-share indicator that helps compare profitability across periods, particularly when tracking growth consistency alongside revenue performance.

Segment snapshot: Healthcare and Education

Segment-wise numbers in the provided extract showed Healthcare revenue at ₹404.92 crore and Education revenue at ₹26.39 crore for Q1 FY27. These two segments together broadly align with the scale of quarterly sales disclosed.

The segment split indicates that Healthcare remains the dominant contributor to the company’s quarterly performance, with Education as a smaller but separately reported business line. No segment margin details were included in the provided data.

Dividend reference from the March 2026 quarter

The extract also referenced a dividend declared in the quarter ending March 2026. Kovai Medical Center & Hospital Ltd declared a dividend of ₹15.00 per share on 22 May 2026, translating to a dividend yield of 0.43% as cited in the same note.

While this dividend item does not relate to Q1 FY27 directly, it provides context on shareholder payouts around the end of FY26.

FY26 performance and audit note mentioned in the extract

For the financial year ended March 31, 2026 (FY26), the extract stated profit after tax (PAT) of ₹244.46 crore, up 17% from ₹208.95 crore in the previous year. It also stated operating income rose 15.65% to ₹1,585.64 crore from ₹1,371.11 crore in FY25.

An audit-related note included in the extract said statutory auditor M/s VKS Aiyer & Co issued an unmodified opinion on the financial statements, while noting observations regarding non-registration of certain lease agreements and immovable property titles that were described as sub judice or pending resolution.

Summary table of key reported numbers

Market impact: what the numbers signal

The quarter’s results show growth across sales, revenue/total income, and net profit, with EPS also rising year-on-year. The reported operating margin increased slightly to 28.76%, suggesting that operating profitability held up as the company expanded revenue. Segment disclosures showed healthcare revenue at ₹404.92 crore and education revenue at ₹26.39 crore in Q1 FY27, underscoring the healthcare business as the primary driver of quarterly scale.

The information provided does not include stock price movement, management commentary, or forward guidance. As a result, the market reaction and outlook expectations are not addressed in the disclosed extract.

Analysis: why this quarter matters

For a hospital operator, consistent year-on-year growth in both revenue and net profit is closely watched because it can reflect underlying demand and execution strength. In this quarter, net profit growth (20.72%) outpaced sales growth (15.34%), which coincided with a modest improvement in operating margin. The reported PBDT increase to ₹123.27 crore also points to stronger pre-depreciation profitability in the quarter.

The FY26 audit note included in the extract is also relevant context. While the auditor issued an unmodified opinion, the reference to non-registration of certain lease agreements and immovable property titles being sub judice or pending resolution is a disclosure investors often track for governance and compliance risk monitoring.

Conclusion

Kovai Medical Center and Hospital’s Q1 FY27 numbers showed year-on-year gains in sales, revenue/total income, and net profit, with EPS rising to ₹63.14 and OPM at 28.76%. Segment data indicated healthcare remained the core contributor during the quarter. The next key datapoints for investors would be subsequent quarterly filings and any further disclosures related to the audit observations referenced for FY26.